|

Oral Supplementation of Glutamine on Gastric Cancer Patients After Gastrectomy

RECRUITINGN/ASponsored by National Taiwan University Hospital
Actively Recruiting
PhaseN/A
SponsorNational Taiwan University Hospital
Started2023-02-21
Est. completion2026-08-30
Eligibility
Age20 Years+
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT06027242

Summary

Glutamine has the potentials of immunomodulation and adjustment of protein metabolism. The primary objective of this study is to evaluate the efficacy of glutamine on sarcopenia in gastric adenocarcinoma patients undergoing gastrectomy. The secondary endpoints, including the physical activity, weight loss, and nutritional profiles, will be evaluated among these patients.

Eligibility

Age: 20 Years+Healthy volunteers accepted
Inclusion Criteria:

* adult gastric cancer receiving gastrectomy

Exclusion Criteria:

* Hepatic insufficiency
* Renal insufficiency
* can not tolerate oral or enteral feeding 7 days after gastrectomy
* can not receive computed tomograph
* can not waer the wearable devices

Conditions4

CancerGastric CancerGastrostomyImmunonutrition

Browse More Trials

Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.